Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs Magnesium Sulfate in Severe Preeclampsia
NCT04539379Completed
- Sponsor
- Zagazig University
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of labetalol in preeclampsia (2 arms), sponsored by Zagazig University. Primary endpoint: Mean Cerebral Blood Flow Velocity at 6 hours. Started Oct 2020; status: completed.
02
Drugs
labetalol
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04539379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539379.